Castillo-Aguilera Omar, Depreux Patrick, Halby Ludovic, Arimondo Paola B, Goossens Laurence
Univ. Lille, ICPAL, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, 3 rue du Pr. Laguesse, F-59000 Lille, France.
FRE3600 Epigenetic Targeting of Cancer, CNRS, 31035 Toulouse, France.
Biomolecules. 2017 Jan 5;7(1):3. doi: 10.3390/biom7010003.
Chromatin can adopt a decondensed state linked to gene transcription (euchromatin) and a condensed state linked to transcriptional repression (heterochromatin). These states are controlled by epigenetic modulators that are active on either the DNA or the histones and are tightly associated to each other. Methylation of both DNA and histones is involved in either the activation or silencing of genes and their crosstalk. Since DNA/histone methylation patterns are altered in cancers, molecules that target these modifications are interesting therapeutic tools. We present herein a vast panel of DNA methyltransferase inhibitors classified according to their mechanism, as well as selected histone methyltransferase inhibitors sharing a common mode of action.
染色质可呈现与基因转录相关的解聚状态(常染色质)和与转录抑制相关的凝聚状态(异染色质)。这些状态由对DNA或组蛋白起作用且彼此紧密相关的表观遗传调节剂控制。DNA和组蛋白的甲基化都参与基因的激活或沉默及其相互作用。由于癌症中DNA/组蛋白甲基化模式会发生改变,靶向这些修饰的分子是很有前景的治疗工具。我们在此展示了根据作用机制分类的大量DNA甲基转移酶抑制剂,以及具有共同作用模式的选定组蛋白甲基转移酶抑制剂。